The research project of Dr. Edouard Baulier, a postdoctoral fellow in Dr. Debora Farber’s UCLA laboratory, is designed to find a treatment for Ocular Albinism type 1 (OA1) by using two recently discovered biology tools: induced pluripotent stem cells (iPSCs) and CRISPR/Cas9, a gene-editing tool.

"It gives our patients and our team a sense of being a part of something much bigger than our little practice.  We are contributing to the future of our kids and that increases morale of the staff and perception of our patients.  Who doesn’t want to know that what they just spent is also helping others?" - Dr. Jason Tu on being a part of VOC's Optometric Partner Program